Zealand Pharma A/S | ZEAL - Fremdkapital

Aktienkurs
265.10
Täglich Wechseln
2.30 0.88%
Monatlich
-32.04%
Jährlich
-54.72%
Q1 Prognose
222.73




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Revvity USD 2.63B 543K 2025-12
Tectonic Therapeutic USD 100K 86K 2025-09
Tilray USD 279.22M 18.87M 2025-03
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 219.47M 839K 2025-09